Glenmark Pharmaceuticals
GLENMARK.NS
$12.66
Share price
-1.30%
Change (1 day)
83.74%
Change (1 year)
Categories
Glenmark Pharmaceuticals (GLENMARK.NS) - Net assets
Net assets on the balance sheet as of September 2023 : $1.17 B
According to Glenmark Pharmaceuticals
's latest financial reports the company has $1.17 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Glenmark Pharmaceuticals - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-03-31 | $1.19 B | -3.71% |
| 2022-03-31 | $1.24 B | 29.41% |
| 2021-03-31 | $0.96 B | 19.48% |
| 2020-03-31 | $0.80 B | -0.27% |
| 2019-03-31 | $0.80 B | -5.96% |
| 2018-03-31 | $0.85 B | 12.61% |
| 2017-03-31 | $0.76 B | 18.49% |
| 2016-03-31 | $0.64 B | 34.05% |
| 2015-03-31 | $0.47 B | -4.16% |
| 2014-03-31 | $0.50 B | -2.49% |
| 2013-03-31 | $0.51 B | 7.65% |
| 2012-03-31 | $0.47 B | 3.11% |
| 2011-03-31 | $0.46 B | -12.48% |
| 2010-03-31 | $0.52 B | 67.65% |
| 2009-03-31 | $0.31 B | -17.22% |
| 2008-03-31 | $0.38 B | 139.59% |
| 2007-03-31 | $0.15 B | 80.07% |
| 2006-03-31 | $88.28 M | 17.04% |
| 2005-03-31 | $75.43 M | 39.22% |
| 2004-03-31 | $54.18 M |